New leadership and new business units in Eli Lilly and Company
On August 17, 2021, Lilly announced that it was undergoing leadership and structural changes. The company announced the company's senior vice president Ilya Yuffa will be promoted to president of Lilly International, the company's main operations outside of the US. The company also announced that it was going to be splitting up its Bio-Medicines division into Lilly Neuroscience and Lilly Immunology. By dividing the sections, the company hopes that each section can focus entirely on the assignments to those specific units to deliver more quality products.
Structural|Discontinued ActivityIn response to volatile demand in the wake of the first COVID-19 surge, the company undertook a comprehensive cost reduction program, aimed at shoring up labor and supply costs.
Lorem Ipsum text header Report Title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas non leo lacinia, consectetur ipsum non, pretium augue. Vestibulum accumsan dignissim massa, eu scelerisque mi malesuada ut. Aliquam scelerisque facilisis nisl ac varius. Nunc luctus nunc vel eros iaculis, vitae tristique ante fringilla. Ut vitae vulputate est, vel lacinia nisi. Curabitur eget nulla vitae mi faucibus imperdiet. Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.
Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.